Physician profile
Larry D Allen
NPI 1942310818
$973.24
in general payments reported to CMS, 2019-2025
17 companies · $19.11 in 2025
The $19.11 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.87 · 2020: $146 · 2021: $430 · 2022: $243 · 2023: $103 · 2024: $17.88 · 2025: $19.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $139.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $209.80 | 2020-2024 | Ozempic, Rybelsus |
| Lilly USA, LLC | $174.32 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $98.75 | 2021-2022 | |
| Glaxosmithkline, LLC. | $84.93 | 2020-2022 | |
| Pfizer INC. | $78.87 | 2021-2023 | |
| Abbvie INC. | $60.56 | 2021-2023 | Ubrelvy |
| Sanofi Pasteur INC. | $56.12 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $47.42 | 2021-2022 | |
| Amgen INC. | $24.54 | 2022 | |
| Boston Scientific Corporation | $23.60 | 2020 | |
| Collegium Pharmaceutical, INC. | $19.11 | 2025 | Jornay Pm |
| Abbott Laboratories | $18.12 | 2021 | |
| Bioventus LLC | $16.96 | 2021 | |
| Xeris Pharmaceuticals, INC. | $16.26 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $16.24 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $16.05 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $11.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.